Skip to main content

Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study.

Citation
Salisbury-Ruf, C. T., et al. “Bid Maintains Mitochondrial Cristae Structure And Function And Protects Against Cardiac Disease In An Integrative Genomics Study.”. Elife.
Center Vanderbilt University
Author Christi T Salisbury-Ruf, Clinton C Bertram, Aurelia Vergeade, Daniel S Lark, Qiong Shi, Marlene L Heberling, Niki L Fortune, Donald Okoye, Gray Jerome, Quinn S Wells, Josh Fessel, Javid Moslehi, Heidi Chen, Jackson Roberts, Olivier Boutaud, Eric R Gamazon, Sandra S Zinkel
Keywords Bcl-2 family, Cell Biology, cristae, electronic health record, human, human genetics & genomics, maize, mitochondria, mouse, myocardial infarction
Abstract

Bcl-2 family proteins reorganize mitochondrial membranes during apoptosis, to form pores and rearrange cristae. In vitro and in vivo analysis integrated with human genetics reveals a novel homeostatic mitochondrial function for Bcl-2 family protein Bid. Loss of full-length Bid results in apoptosis-independent, irregular cristae with decreased respiration. mice display stress-induced myocardial dysfunction and damage. A gene-based approach applied to a biobank, validated in two independent GWAS studies, reveals that decreased genetically determined BID expression associates with myocardial infarction (MI) susceptibility. Patients in the bottom 5% of the expression distribution exhibit >4 fold increased MI risk. Carrier status with nonsynonymous variation in Bid's membrane binding domain, Bid, associates with MI predisposition. Furthermore, Bid but not Bid associates with Mcl-1, previously implicated in cristae stability; decreased MCL-1 expression associates with MI. Our results identify a role for Bid in homeostatic mitochondrial cristae reorganization, that we link to human cardiac disease.

Year of Publication
2018
Journal
eLife
Volume
7
Date Published
12/2018
ISSN Number
2050-084X
DOI
10.7554/eLife.40907
Alternate Journal
Elife
PMID
30281024
PMCID
PMC6234033
Download citation